These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. The role of urocortins in the cardiovascular system. Walczewska J; Dzieza-Grudnik A; Siga O; Grodzicki T J Physiol Pharmacol; 2014 Dec; 65(6):753-66. PubMed ID: 25554979 [TBL] [Abstract][Full Text] [Related]
16. Cardioprotection mediated by urocortin is dependent on PKCepsilon activation. Lawrence KM; Kabir AM; Bellahcene M; Davidson S; Cao XB; McCormick J; Mesquita RA; Carroll CJ; Chanalaris A; Townsend PA; Hubank M; Stephanou A; Knight RA; Marber MS; Latchman DS FASEB J; 2005 May; 19(7):831-3. PubMed ID: 15764590 [TBL] [Abstract][Full Text] [Related]
17. D-amino acid-substituted analogs of corticotropin-releasing hormone (CRH) and urocortin with selective agonist activity at CRH1 and CRH2beta receptors. Wei ET; Thomas HA; Christian HC; Buckingham JC; Kishimoto T Peptides; 1998; 19(7):1183-90. PubMed ID: 9786168 [TBL] [Abstract][Full Text] [Related]
18. Urocortin, but not corticotropin-releasing hormone (CRH), activates the mitogen-activated protein kinase signal transduction pathway in human pregnant myometrium: an effect mediated via R1alpha and R2beta CRH receptor subtypes and stimulation of Gq-proteins. Grammatopoulos DK; Randeva HS; Levine MA; Katsanou ES; Hillhouse EW Mol Endocrinol; 2000 Dec; 14(12):2076-91. PubMed ID: 11117536 [TBL] [Abstract][Full Text] [Related]